Text


Low Dose Naltrexone  


 
We need your help!
We've provided low dose naltrexone to 1000's of patients with immune disorders, but people still don't know where to find this life altering medication.
If you suffer from Lyme disease, Multiple Sclerosis, Chronic Fatique or other illnesses and have found relief with LDN, help us become a resource for others in our community.

Visit www.lowdosenaltrexone.org for more information and take a minute to email them at  [email protected] to recommend The Compounding Center as a reputable source for LDN. As the site suggests, our LDN capsules are immediate release, we use a third party lab for testing and our pharmacy is PCAB accredited. Even with this information, the low dose naltrexone organization relies on customer recommendations to add us to their list of compounding pharmacies.

We appreciate your help in spreading the good word about the positive effects of LDN!

Want to learn more about low dose naltrexone? Click here.


Benefits: 
  • Improved immune functioning
  • Reduced inflammation
  • Pain relief
  • Mild or no side effects
  • Non-addictive

Preparations:

  • Immediate release oral capsule
    •
     
    Low dose naltrexone (LDN) cannot be used in conjunction  
    with narcotic pain relievers. LDN blocks the effects of  
    these drugs and could cause withdrawal symptoms.
    How does LDN work?
    Low dose naltrexone attaches to opioid receptors in  
    the brain and immune system cells, temporarily blocking  
    endorphins from attaching to those cells. Because of this,  
    the body signals for greater endorphin production.  
    This raises the endorphin levels, relieving pain and  
    regulating immune system function.

    References

    www.lowdosenaltrexone.org 
    Bihari B (2013) Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function. Altern Ther Health Med 19(2):56-65  
    Younger, J, Noor, N, Mccue, R, Mackey, S. Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis & Rheumatism. 2013:529- 538.  
    Younger, J, Parkitny, L, Mclain, D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol Clinical Rheumatology.  
    2014:451-459. 
     


    Call Us for information and pricing
    703-779-3301
     
    STAY CONNECTED: